我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Acute Neuralgia in Infants can be managed with Cerebral Hypothermia and Temperature Control

Misav Mira

In the adult intensive care unit, brain hypothermia (BHT) has been reported to be effective in neuroprotection after resuscitation and cardiac arrest. In contrast, in the neonatal intensive care unit, the pathophysiology of brain injury from hypoxic-ischemic encephalopathy (HIE) has been attributed to ischemia/reperfusion-induced circulatory impairment using neonatal brain cryotherapy. The International Liaison Committee on Resuscitation, 2010, recommends brain cryotherapy for HIE associated with severe neonatal pseudoparenchymal death. The utility of BHT for neuroprotection in infants and children, especially childhood acute encephalopathy, is expected. In theory, BHT could be useful in basic medical research and animal experiments. However, clinical plans for the treatment of pediatric acute encephalopathy have limitations. No international studies have been conducted and there is no clinical evidence of neuroprotection using BHT. This review describes the pathogenesis of neuronal injury in hypoxic and hypoperfused brains. History of BHT, its effects and mechanism of action. Methods of Cooling and Monitoring BHT; Side Effects of BHT. Review recent literature on target temperature management used to maintain and control body temperature in adults in the ICU. Finally, we discuss the development of BHT and targeted temperature management as a treatment for pediatric acute encephalopathy.